These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24699551)

  • 21. Percutaneous coronary intervention for poor coronary microcirculation reperfusion of patients with stable angina pectoris.
    Li JS; Zhao XJ; Ma BX; Wang Z
    J Biol Regul Homeost Agents; 2016; 30(3):733-741. PubMed ID: 27655490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of liposomal prostaglandin E1 on periprocedural myocardial injury in patients with unstable angina undergoing an elective percutaneous coronary intervention.
    Fan Y; Jiang Y; Fu X; Cai J; Wang Y; Li W; Gu X; Xing K; Bai S; Bi X
    Coron Artery Dis; 2015 Dec; 26(8):671-7. PubMed ID: 26267747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remote ischaemic postconditioning: does it protect against ischaemic damage in percutaneous coronary revascularisation? Randomised placebo-controlled clinical trial.
    Carrasco-Chinchilla F; Muñoz-García AJ; Domínguez-Franco A; Millán-Vázquez G; Guerrero-Molina A; Ortiz-García C; Enguix-Armada A; Alonso-Briales JH; Hernández-García JM; de Teresa-Galván E; Jiménez-Navarro MF
    Heart; 2013 Oct; 99(19):1431-7. PubMed ID: 23850844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction).
    Niccoli G; Rigattieri S; De Vita MR; Valgimigli M; Corvo P; Fabbiocchi F; Romagnoli E; De Caterina AR; La Torre G; Lo Schiavo P; Tarantino F; Ferrari R; Tomai F; Olivares P; Cosentino N; D'Amario D; Leone AM; Porto I; Burzotta F; Trani C; Crea F
    JACC Cardiovasc Interv; 2013 Jun; 6(6):580-9. PubMed ID: 23683738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycogen phosphorylase isoenzyme BB, creatine kinase isoenzyme MB and troponin I for monitoring patients with percutaneous coronary intervention - a pilot study.
    Skitek M; Kranjec I; Jerin A
    Med Glas (Zenica); 2014 Feb; 11(1):13-8. PubMed ID: 24496335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions.
    Liu T; Xie Y; Zhou YJ; Li YP; Ma HY; Guo YH; Liu YY; Zhao YX; Shi DM
    Chin Med J (Engl); 2009 Aug; 122(15):1732-7. PubMed ID: 19781316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
    Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
    Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes.
    Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
    Am J Cardiol; 2009 Nov; 104(9):1210-5. PubMed ID: 19840564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracoronary injection of adenosine before reperfusion in patients with ST-segment elevation myocardial infarction: a randomized controlled clinical trial.
    Garcia-Dorado D; García-del-Blanco B; Otaegui I; Rodríguez-Palomares J; Pineda V; Gimeno F; Ruiz-Salmerón R; Elizaga J; Evangelista A; Fernandez-Avilés F; San-Román A; Ferreira-González I
    Int J Cardiol; 2014 Dec; 177(3):935-41. PubMed ID: 25449504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial.
    Sardella G; Lucisano L; Mancone M; Conti G; Calcagno S; Stio RE; Pennacchi M; Biondi-Zoccai G; Canali E; Fedele F
    Int J Cardiol; 2013 Oct; 168(4):3715-20. PubMed ID: 23849964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of adenosine intracoronary bolus on myonecrosis occurrence in elective PCI (RACE trial).
    Sardella G; Lucisano L; Mancone M; Canali E; De Carlo C; Stio RE; Calcagno S; Brasolin B; Fedele F
    Int J Cardiol; 2012 Mar; 155(3):456-9. PubMed ID: 22240750
    [No Abstract]   [Full Text] [Related]  

  • 32. A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention.
    Pelliccia F; Pasceri V; Marazzi G; Rosano G; Greco C; Gaudio C
    Am Heart J; 2012 Jun; 163(6):1019-23. PubMed ID: 22709755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Intracoronary Adenosine on Myonecrosis in Patients with Unstable Angina Pectoris Undergoing Percutaneous Coronary Intervention.
    Kizilirmak F; Gunes HM; Demir GG; Gokdeniz T; Guler E; Cakal B; Omaygenç MO; Yılmaz F; Savur U; Barutcu I
    Cardiovasc Drugs Ther; 2015 Dec; 29(6):519-526. PubMed ID: 26631392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of electroacupuncture pretreatment for myocardial injury in patients undergoing percutaneous coronary intervention: A randomized clinical trial with a 2-year follow-up.
    Wang Q; Liang D; Wang F; Li W; Han Y; Zhang W; Xie Y; Xin W; Zhou B; Sun D; Cao F; Xiong L
    Int J Cardiol; 2015 Sep; 194():28-35. PubMed ID: 26011261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of trimetazidine treatment in patients with type 2 diabetes undergoing percutaneous coronary intervention for AMI.
    Li R; Tang X; Jing Q; Wang Q; Yang M; Han X; Zhao J; Yu X
    Am J Emerg Med; 2017 Nov; 35(11):1657-1661. PubMed ID: 28587952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of trimetazidine therapy on left ventricular function after percutaneous coronary intervention].
    Xu XH; Zhang WJ; Zhou YJ; Zhou ZM; Ma HY; Hu B; Kang YP; Luo FF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Mar; 41(3):205-9. PubMed ID: 23879944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of short-term high-dose atorvastatin on systemic inflammatory response and myocardial ischemic injury in patients with unstable angina pectoris undergoing percutaneous coronary intervention.
    Sun F; Yin Z; Shi Q; Zhao B; Wang S
    Chin Med J (Engl); 2014; 127(21):3732-7. PubMed ID: 25382328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bradykinin preconditioning in coronary artery bypass grafting.
    Wei M; Wang X; Kuukasjärvi P; Laurikka J; Rinne T; Honkonen EL; Tarkka M
    Ann Thorac Surg; 2004 Aug; 78(2):492-7. PubMed ID: 15276504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adenosine preconditioning reduces myocardial injury in patients undergoing off-pump coronary artery bypass grafting surgery].
    Yang J; Li LH
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2313-5. PubMed ID: 18036291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nicorandil prevents microvascular dysfunction resulting from PCI in patients with stable angina pectoris: a randomised study.
    Hirohata A; Yamamoto K; Hirose E; Kobayashi Y; Takafuji H; Sano F; Matsumoto K; Ohara M; Yoshioka R; Takinami H; Ohe T
    EuroIntervention; 2014 Jan; 9(9):1050-6. PubMed ID: 24457276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.